搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
MedPage Today
3 小时
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in ...
Everyday Health on MSN
3 天
Sickle Cell Anemia Symptoms
The hallmark symptom of sickle cell anemia is pain, particularly episodes of sudden pain, sometimes called sickle cell crises ...
bme.jhu.edu
13 天
Johns Hopkins team awarded funding for noninvasive anemia test
The two-year project aims to make anemia screening more accessible on a global scale, particularly in low-resource areas with ...
1 小时
The Changing Market Dynamics of Immune Thrombocytopenia, Aplastic Anemia, and Diamond ...
Blood disorders are a group of conditions that affect the production, function, or structure of blood cells, leading to ...
6 小时
Disc presents clinical, translational data across portfolio at ASH meeting
Complete SAD/MAD data from the Phase 1 trial of DISC-3405 in healthy volunteers were presented. In the SAD portion of this trial, healthy males and females ages 18 to 65 were given a single dose of ...
Daily
1 天
From Womb to Growth: Study reveals Implications of Neonatal Anemia on child Health
Neonatal anemia can have lasting impacts on the growth and development of children. Anemia is highly prevalent among pregnant ...
Medscape
7 天
Sotagliflozin Helps Manage Anemia in Patients With Type 2 Diabetes and Chronic Kidney Disease
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
7 小时
Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate ...
Beam Therapeutics Inc. (NASDAQ:BEAM) revealed new safety and efficacy data from its BEACON Phase 1/2 trial of BEAM-101 in ...
SHINE
10 小时
Locally-developed gene editing technology cures boy with serious blood disorder
The treatment CS-101 uses innovative transformer Base Editing (tBE) technology to help people with severe diseases such as ...
11 小时
ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug
J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...
Too Old to Operate
11 天
Impact of HIF-PHIs on Hemoglobin and Erythrocyte Indices in CKD
The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈